Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 2014. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) under the GlaxoSmithKline US Deferred Performance Share Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific equity transaction rather than financial performance results.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The only reported change is an increase in the American Depositary Shares (ADSs) held by Mr. D E Troy.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, or discussion of risks and contingencies. It strictly details a transaction where Mr. D E Troy acquired 310.934 ADSs at a price of $54.40 per ADS following the re-investment of the dividend paid on July 10, 2014.
Investor Verification Points
- Verify the total number of ADSs held by Mr. D E Troy post-transaction.
- Confirm the dividend reinvestment terms of the US Deferred Performance Share Plan.
- Check for any other concurrent insider trading notifications for the same period.